SCHEMBL5675079

SCHEMBL5675079

CN(C)CC1CN(C2(c3ccccc3)CCCCC2)CCC1(O)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 12/20 0.46
OPRK1 P41145 12/20 0.46
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
CYP2B6 P20813 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
PRCP P42785 1/20 0.41
SLC6A3 Q01959 1/20 0.41
GRIN1 Q05586 1/20 0.41
KCNH2 Q12809 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
OPRM1 P35372 6/20 0.41
ARRB1 P49407 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5677341 0.99 OPRK1 (0.46) OPRD1OPRK1ALDH1A1SMN1; SMN2GRIN2D
Hydrochloric Acid SCHEMBL27582452 0.85 OPRD1 (0.49) OPRD1OPRK1ALDH1A1SMN1; SMN2SLC6A2
SCHEMBL5674046 0.82 SLC6A2 (0.49) OPRD1OPRK1ALDH1A1SMN1; SMN2GRIN2D
SCHEMBL5675100 0.81 OPRK1 (0.62) OPRD1OPRK1SLC6A2SLC6A4OPRM1
Hydrochloric Acid SCHEMBL5677586 0.81 OPRM1 (0.50) OPRD1OPRK1ALDH1A1SMN1; SMN2GRIN2D
SCHEMBL5673865 0.80 SMN1; SMN2 (0.57) OPRD1OPRK1SMN1; SMN2SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL5677175 0.80 OPRK1 (0.62) OPRD1OPRK1SLC6A2SLC6A4OPRM1
Hydrochloric Acid SCHEMBL5677140 0.80 SMN1; SMN2 (0.59) OPRD1OPRK1ALDH1A1SMN1; SMN2SLC6A2
SCHEMBL5673834 0.79 SLC6A2 (0.46) OPRD1OPRK1ALDH1A1SMN1; SMN2GRIN2D
SCHEMBL5675035 0.79 OPRD1 (0.68) OPRD1OPRK1SLC6A2SLC6A4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049327-B2 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics GRUENENTHAL GMBH (DE) 2006-05-23 US claimed
EP-1370529-B1 SUBSTITUTED DIMETHYL- 1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS GRUENENTHAL GMBH (DE) 2006-01-11 EP claimed
US-20040127516-A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics GRUENENTHAL GMBH (DE) 2004-07-01 US claimed
CN-1496352-A Substituted dimethyl- [ 1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl ] -amines and their use as analgesics 2004-05-12 CN claimed
EP-1370529-A1 SUBSTITUTED DIMETHYL- 1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS Grünenthal GmbH (DE) 2003-12-17 EP claimed
WO-2002072550-A1 SUBSTITUTED DIMETHYL-[1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS Grünenthal GmbH (DE) 2002-09-19 WO claimed
US-7049327-B2 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics GRUENENTHAL GMBH (DE) 2006-05-23 US disclosed
EP-1370529-B1 SUBSTITUTED DIMETHYL- 1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS GRUENENTHAL GMBH (DE) 2006-01-11 EP disclosed
US-20040127516-A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics GRUENENTHAL GMBH (DE) 2004-07-01 US disclosed
CN-1496352-A Substituted dimethyl- [ 1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl ] -amines and their use as analgesics 2004-05-12 CN disclosed
EP-1370529-A1 SUBSTITUTED DIMETHYL- 1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS Grünenthal GmbH (DE) 2003-12-17 EP disclosed
WO-2002072550-A1 SUBSTITUTED DIMETHYL-[1-(1-PHENYL-CYCLOHEXYL)-PIPERIDIN-3-YL METHYL]-AMINES AND THE USE OF THE SAME AS ANALGESICS Grünenthal GmbH (DE) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127516-A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics OPRM1, OPRK1, PNMT OPRD1 6/4885OPRK1 2/4885ALDH1A1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.